Effects of CYP2C9 polymorphism on the pharmacokinetics of irbesartan in healthy Korean subjects

被引：0
|
作者：
Kim, Mi-Jung
Bae, Jung -Woo
Han, Ho-Kyun
Choi, Sun-Ok
Kim, Ok-Hee
Jang, Choon-Gon
Lee, Jin-Hee
Kim, Nam-Tae
Lee, Seok-Yong
机构：
[1] Sungkyunkwan Univ, Coll Pharm, Seoul, South Korea
[2] Natl Inst Toxicol Res, Seoul, South Korea
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
Irbesartan; CYP2C9; polymorphism; pharmacokinetics;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [21] Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
    Makiko Kusama
    Kazuya Maeda
    Koji Chiba
    Akinori Aoyama
    Yuichi Sugiyama
    Pharmaceutical Research, 2009, 26
  • [22] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Hyun-Jee Lee
    Young-Hoon Kim
    Se-Hyung Kim
    Choong-Min Lee
    Ae-Yun Yang
    Choon-Gon Jang
    Seok-Yong Lee
    Jung-Woo Bae
    Chang-Ik Choi
    Archives of Pharmacal Research, 2016, 39 : 1013 - 1019
  • [23] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Lee, Hyun-Jee
    Kim, Young-Hoon
    Kim, Se-Hyung
    Lee, Choong-Min
    Yang, Ae-Yun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Bae, Jung-Woo
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (07) : 1013 - 1019
  • [24] Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
    Kusama, Makiko
    Maeda, Kazuya
    Chiba, Koji
    Aoyama, Akinori
    Sugiyama, Yuichi
    PHARMACEUTICAL RESEARCH, 2009, 26 (04) : 822 - 835
  • [25] Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Rosuvastatin in Healthy Taiwanese Subjects
    Finkelman, Richard D.
    Wang, Tzung-Dau
    Wang, Yi
    Azumaya, Connie T.
    Birmingham, Bruce K.
    Wissmar, Jenny
    Mosqueda-Garcia, Rogelio
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (01): : 33 - 40
  • [26] Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes
    Cho, Chang-Keun
    Kang, Pureum
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (11-12) : 939 - 953
  • [27] Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes
    Chang-Keun Cho
    Pureum Kang
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Chang-Ik Choi
    Archives of Pharmacal Research, 2023, 46 : 939 - 953
  • [28] Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
    Bae, Jung-Woo
    Choi, Chang-Ik
    Jang, Choon-Gon
    Lee, Seok-Yong
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) : 550 - 555
  • [29] Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics
    Jung-woo Bae
    Chang-ik Choi
    Mi-jeong Kim
    Da-hee Oh
    Seul-ki Keum
    Jung-in Park
    Bo-hye Kim
    Hye-kyoung Bang
    Sung-gon Oh
    Byung-sung Kang
    Hyun-joo Park
    Hae-deun Kim
    Ji-hey Ha
    Hee-jung Shin
    Young-hoon Kim
    Han-sung Na
    Myeon-woo Chung
    Choon-gon Jang
    Seok-yong Lee
    Acta Pharmacologica Sinica, 2011, 32 : 1303 - 1308
  • [30] Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics
    Bae, Jung-woo
    Choi, Chang-ik
    Kim, Mi-jeong
    Oh, Da-hee
    Keum, Seul-ki
    Park, Jung-in
    Kim, Bo-hye
    Bang, Hye-kyoung
    Oh, Sung-gon
    Kang, Byung-sung
    Lee, Hye-in
    Lee, Yun-jeong
    Park, Hyun-joo
    Kim, Hae-deun
    Ha, Ji-hey
    Shin, Hee-jung
    Kim, Young-hoon
    Na, Han-sung
    Chung, Myeon-woo
    Han, Soon-young
    Kim, Seung-hee
    Jang, Choon-gon
    Lee, Seok-yong
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (10) : 1303 - 1308
12345